Initial investigations into defining AIP as a tumor suppressor in the pituitary gland focused on cell proliferation and GH secretion in AIP knockout, knockdown, and expression of mutant AIP variants in different cell types including the GH3 pituitary tumor cell line, 293 cells, and human fibroblasts (7). The gene discussed is GH1; the disease is pituitary tumor.